Hap Trading, LLC Ocugen, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$0.82 - $1.33 $63,877 - $103,607	-77,900 Reduced 88.22%	10,400 $1,000
Q4 2022 Feb 14, 2023	SELL	$1.11 - $1.87 $25,086 - $42,262	-22,600 Reduced 20.38%	88,300 $2,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $55,300 - $97,960	-31,600 Reduced 22.18%	110,900 $7,000
Q2 2022 Aug 12, 2022	SELL	$1.83 - $3.45 $118,767 - $223,905	-64,900 Reduced 31.29%	142,500 $12,000
Q1 2022 May 12, 2022	BUY	$2.34 - $4.72 $52,182 - $105,256	22,300 Added 12.05%	207,400 $45,000
Q4 2021 Feb 14, 2022	BUY	$4.38 - $15.67 $236,958 - $847,747	54,100 Added 41.3%	185,100 $78,000
Q3 2021 Nov 10, 2021	BUY	$6.36 - $8.51 $226,416 - $302,956	35,600 Added 37.32%	131,000 $119,000
Q2 2021 Aug 11, 2021	BUY	$5.52 - $15.68 $365,424 - $1.04 Million	66,200 Added 226.71%	95,400 $94,000
Q1 2021 May 14, 2021	BUY	$1.66 - $15.81 $48,472 - $461,652	29,200 New	29,200 $38,000

125

78.4M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.